Literature DB >> 23718274

Pre-operative and early post-operative factors associated with surgical site infection after laparoscopic sleeve gastrectomy.

Jaime Ruiz-Tovar1, Inmaculada Oller, Carolina Llavero, Antonio Arroyo, Jose Luis Muñoz, Alicia Calero, María Diez, Lorea Zubiaga, Rafael Calpena.   

Abstract

BACKGROUND: Surgical procedures on obese patients are expected to have a high incidence of surgical site infection (SSI). The identification of pre-operative or early post-operative risk factors for SSI may help the surgeon to identify subjects in risk and adequately optimize their status. We conducted a study of the association of comorbidities and pre- and post-operative analytical variables with SSI following laparoscopic sleeve gastrectomy for the treatment of morbid obesity. PATIENTS AND METHODS: We performed a prospective study of all morbidly obese patients undergoing laparoscopic sleeve gastrectomy as a bariatric procedure between 2007 and 2011. An association of clinical and analytical variables with SSI was investigated.
RESULTS: The study included 40 patients with a mean pre-operative body mass index (BMI) of 51.2±7.9 kg/m(2). Surgical site infections appeared in three patients (7.5%), of whom two had an intra-abdominal abscess located in the left hypochondrium and the third had a superficial incisional SSI. Pre-operatively, a BMI >45 kg/m(2) (OR 8.7; p=0.008), restrictive disorders identified by pulmonary function tests (OR 10.0; p=0.012), a serum total protein concentration <5.3 g/dL (OR 13; p=0.003), a plasma cortisol >30 mcg/dL (OR 13.0; p=0.003), and a mean corpuscular volume (MCV) <82 fL (OR 1.6; p=0.04) were associated with post-operative SSI. Post-operatively, a serum glucose >128 mg/dL (OR 4.7; p=0.012) and hemoglobin <11g/dL (OR 7.5; p=0.002) were associated with SSI.
CONCLUSIONS: The study supports the role of restrictive lung disorders and the values specified above for preoperative BMI, serum total protein and cortisol concentrations, and MCV, and of post-operative anemia and hyperglycemia as risk factors for SSI. In these situations, the surgeon must be aware of and seek to control these risk factors.

Entities:  

Mesh:

Year:  2013        PMID: 23718274     DOI: 10.1089/sur.2012.114

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  3 in total

1.  Plasma and Interstitial Fluid Pharmacokinetics of Prophylactic Cefazolin in Elective Bariatric Surgery Patients.

Authors:  Rochelle L Ryan; Dwane Jackson; George Hopkins; Victoria Eley; Rebecca Christensen; Andre A J Van Zundert; Steven C Wallis; Jeffrey Lipman; Suzanne L Parker; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2022-06-28       Impact factor: 5.938

2.  COMPLICATIONS RELATED TO GASTRIC BYPASS PERFORMED WITH DIFFERENT GASTROJEJUNAL DIAMETERS.

Authors:  José Sampaio-Neto; Alcides José Branco-Filho; Luis Sérgio Nassif; Anne Caroline Broska; Douglas Jun Kamei; André Thá Nassif
Journal:  Arq Bras Cir Dig       Date:  2016

3.  Percutaneous Electrical Neurostimulation (PENS) of Dermatome T6 with an Ambulatory Self-applied Patch vs PENS of Dermatome T6 with Conventional Procedure: Effect on Appetite and Weight Loss in Moderately Obese Patients.

Authors:  Mohammed Abdel-Kadar
Journal:  Obes Surg       Date:  2016-12       Impact factor: 4.129

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.